BIO-TECHNE Corp Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-TECHNE Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIO-TECHNE Corp for February 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 18 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Option Exercise | M | 94.35 | 30,000 | 2,830,500 | 36,849 | |
Feb 18 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Payment of Exercise | F | 411.00 | 17,428 | 7,162,908 | 158,841 | 176.3 K to 158.8 K (-9.89 %) |
Feb 18 2021 | TECH | BIO-TECHNE Corp | Kummeth Charles R. | Chief Executive Off ... | Buy | M | 94.35 | 30,000 | 2,830,500 | 176,269 | 146.3 K to 176.3 K (+20.51 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 39,942 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 39,942 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 401.52 | 600 | 240,911 | 9,137 | 9.7 K to 9.1 K (-6.16 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 401.52 | 600 | 240,911 | 9,137 | 9.7 K to 9.1 K (-6.16 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 400.32 | 9,400 | 3,762,998 | 9,737 | 19.1 K to 9.7 K (-49.12 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Sell | S | 400.32 | 9,400 | 3,762,998 | 9,737 | 19.1 K to 9.7 K (-49.12 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 19,137 | 9.1 K to 19.1 K (+109.45 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Hippel James | Chief Financial Off ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 19,137 | 9.1 K to 19.1 K (+109.45 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 3,538 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 399.12 | 3,326 | 1,327,461 | 6,124 | 9.5 K to 6.1 K (-35.20 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 398.40 | 6,674 | 2,658,891 | 9,450 | 16.1 K to 9.5 K (-41.39 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Option Exercise | M | 106.59 | 10,000 | 1,065,900 | 3,538 | |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 16,124 | 6.1 K to 16.1 K (+163.29 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 399.12 | 3,326 | 1,327,461 | 6,124 | 9.5 K to 6.1 K (-35.20 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Sell | S | 398.40 | 6,674 | 2,658,891 | 9,450 | 16.1 K to 9.5 K (-41.39 %) |
Feb 17 2021 | TECH | BIO-TECHNE Corp | Furlow Brenda S. | SVP - General Couns ... | Buy | M | 106.59 | 10,000 | 1,065,900 | 16,124 | 6.1 K to 16.1 K (+163.29 %) |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | M | 66.90 | 5,000 | 334,500 | 0 | |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Option Exercise | M | 70.35 | 1,000 | 70,350 | 4,000 | |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Sell | S | 385.08 | 6,000 | 2,310,481 | 6,765 | 12.8 K to 6.8 K (-47.00 %) |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Buy | M | 66.90 | 5,000 | 334,500 | 12,765 | 7.8 K to 12.8 K (+64.39 %) |
Feb 10 2021 | TECH | BIO-TECHNE Corp | Nusse Roeland | Director | Buy | M | 70.35 | 1,000 | 70,350 | 7,765 | 6.8 K to 7.8 K (+14.78 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Kelderman Kim | Pres. Diagnostics & ... | Sell | S | 388.45 | 823 | 319,694 | 845 | 1.7 K to 845 (-49.34 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 106.59 | 18,819 | 2,005,917 | 0 | |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 106.59 | 14,114 | 1,504,411 | 0 | |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 385.59 | 1,100 | 424,151 | 1,318 | 2.4 K to 1.3 K (-45.49 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 384.15 | 1,900 | 729,888 | 2,418 | 4.3 K to 2.4 K (-44.00 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 382.60 | 3,700 | 1,415,636 | 4,318 | 8 K to 4.3 K (-46.15 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 381.52 | 2,900 | 1,106,395 | 8,018 | 10.9 K to 8 K (-26.56 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 380.50 | 12,833 | 4,882,918 | 10,918 | 23.8 K to 10.9 K (-54.03 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 379.63 | 4,500 | 1,708,312 | 23,751 | 28.3 K to 23.8 K (-15.93 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 378.29 | 6,000 | 2,269,723 | 28,251 | 34.3 K to 28.3 K (-17.52 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 106.59 | 18,819 | 2,005,917 | 34,251 | 15.4 K to 34.3 K (+121.95 %) |
Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Buy | M | 106.59 | 14,114 | 1,504,411 | 15,432 | 1.3 K to 15.4 K (+1,070.86 %) |